<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04566250</url>
  </required_header>
  <id_info>
    <org_study_id>NOPain1111</org_study_id>
    <nct_id>NCT04566250</nct_id>
  </id_info>
  <brief_title>Non-Opioid Prescriptions After Arthroscopic Surgery in Canada (NO PAin)</brief_title>
  <acronym>NO PAin</acronym>
  <official_title>Non-Opioid Prescriptions After Arthroscopic Surgery in Canada (NO PAin): A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>McMaster University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hamilton Health Sciences Corporation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Physicians' Services Incorporated Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>McMaster University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized controlled trial of 200 patients between the ages of 18 and 65 years&#xD;
      undergoing outpatient knee or shoulder arthroscopy. Patients will be evaluated clinically at&#xD;
      2 and 6 weeks post-operatively. Patients will be recruited from experienced arthroscopic&#xD;
      surgeons at 3 hospital sites in Hamilton, Ontario. All research will be conducted according&#xD;
      to international standards of Good Clinical Practice and institutional research policies and&#xD;
      procedures.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 24, 2021</start_date>
  <completion_date type="Anticipated">April 5, 2023</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Eligible patients will be randomized using the centralized 24-hour computerized randomization system to allocate patients to the control (standard of care) or intervention (non-opioid prescription and infographic) group.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Given that patients in the intervention group will receive a pamphlet explaining how to use their prescription allocation, patient blinding is not feasible. Surgeons cannot be blinded as they will need to sign the prescriptions and provide any necessary advice about the medications being prescribed. Outcome assessors and data analysts will be blinded.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Total oral morphine equivalents (OMEs)</measure>
    <time_frame>6 weeks postoperatively</time_frame>
    <description>The primary outcome is the number of total OMEs consumed as determined by a patient-reported medication diary.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain (Visual Analogue Scale, VAS)</measure>
    <time_frame>6 weeks postoperatively</time_frame>
    <description>The VAS will include a 100mm line, on which patients will be asked to rate their average pain since their surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction (Hospital Consumer Assessment of Health Care Provider and Systems Question, HCAHPS)</measure>
    <time_frame>6 weeks postoperatively</time_frame>
    <description>We used the following modified question from the HCAHPS questionnaire related to satisfaction with pain relief, answered on a Likert scale (never, sometimes, usually, or always): &quot;In the time after surgery, how often was your pain well controlled?&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>OMEs Prescribed</measure>
    <time_frame>6 weeks postoperatively</time_frame>
    <description>As per the medication diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid Refills</measure>
    <time_frame>6 weeks postoperatively</time_frame>
    <description>As per the medication diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>6 weeks postoperatively</time_frame>
    <description>Adverse events, defined as any symptom, sign, illness, or experience that develops or worsens in severity during the course of this study, will be documented.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Knee Arthroscopy</condition>
  <condition>Shoulder Arthroscopy</condition>
  <arm_group>
    <arm_group_label>Non-Opioid Prescription and Infographic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The study intervention will involve 3 components:&#xD;
A standardized non-opioid prescription: A prescription for Naproxen 500mg PO BID PRN x 60 tabs, Acetaminophen 1000mg PO Q6H PRN x 100 500mg tabs and Pantoprazole 20mg PO daily x 30 tabs (to be taken only while utilizing Naproxen). In the case of a Naproxen intolerance, a prescription for Meloxicam 15mg PO BID PRN x 60 tabs will be given.&#xD;
A limited opioid &quot;rescue prescription&quot;: A prescription of Hydromorphone 1mg PO Q4H PRN x 10 tabs will be included on a separate prescription.&#xD;
Patient education infographic: The infographic will contain information on how to take the prescribed medications, along with instructions that the morphine rescue prescription should only be used in cases where the non-opioid pain medications are not providing satisfactory pain control.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The control group is standard of care, which typically includes a prescription for an opioid.</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Non-Opioid Prescription and Infographic</intervention_name>
    <description>The study intervention will involve 3 components:&#xD;
A standardized non-opioid prescription: A prescription for Naproxen 500mg PO BID PRN x 60 tabs, Acetaminophen 1000mg PO Q6H PRN x 100 500mg tabs and Pantoprazole 40mg PO daily x 30 tabs (to be taken only while utilizing Naproxen).&#xD;
A limited opioid &quot;rescue prescription&quot;: A prescription of Hydromorphone 1mg PO Q4H PRN x 10 tabs will be included on a separate prescription.&#xD;
Patient education infographic: The infographic will contain information on how to take the prescribed medications, along with instructions that the morphine rescue prescription should only be used in cases where the non-opioid pain medications are not providing satisfactory pain control.</description>
    <arm_group_label>Non-Opioid Prescription and Infographic</arm_group_label>
    <arm_group_label>Standard of Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients undergoing outpatient knee or shoulder arthroscopy for any of the following&#xD;
             procedures: ACL reconstruction (with or without LET), MPFL reconstruction (not&#xD;
             including TTO), Chondroplasty, Meniscectomy, Meniscal repair Meniscal transplant,&#xD;
             Microfracture, ACI, Fixation of unstable osteochondral lesion, Subacromial&#xD;
             decompression, Rotator cuff repair, Shoulder stabilization, Superior capsule&#xD;
             reconstruction, Biceps tenotomy/tenodesis, Capsular release, SLAP repair, Diagnostic&#xD;
             arthroscopy, Irrigation and/or debridement, Loose body removal, Synovectomy&#xD;
&#xD;
          2. Patients aged 18 years and older&#xD;
&#xD;
          3. Patients who have the ability to speak, understand, and read English&#xD;
&#xD;
          4. Provision of informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients who take or are on a home dose of an opioid medication (i.e. once daily or&#xD;
             more)&#xD;
&#xD;
          2. Patients involved in ongoing litigation or compensation claims for any injury (e.g.&#xD;
             Work Safety Insurance Board, WSIB)&#xD;
&#xD;
          3. Patients involved in another research study that requires a specific post-operative&#xD;
             pain control medication regimen&#xD;
&#xD;
          4. Patients undergoing a knee or shoulder arthroscopy procedure that will likely have an&#xD;
             operative time greater than 3 hours&#xD;
&#xD;
          5. Patients who will undergo concomitant open surgery&#xD;
&#xD;
          6. Patients who require overnight admission&#xD;
&#xD;
          7. Patients with a contraindication or allergy to NSAIDs, acetaminophen, or morphine and&#xD;
             hydromorphone&#xD;
&#xD;
          8. Patients diagnosed with renal disease or cardiac disease&#xD;
&#xD;
          9. Patients who are scheduled for/plan to have an additional surgical procedure during&#xD;
             the 6-week follow-up period&#xD;
&#xD;
         10. Patients who will likely have problems, in the judgement of the investigator, with&#xD;
             maintaining follow-up&#xD;
&#xD;
         11. Any other reason(s) the investigator feels is relevant for excluding the patient&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nicole Simunovic, MSc</last_name>
    <phone>9055212100</phone>
    <email>simunon@mcmaster.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hamilton General Hospital</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N2X2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andrew Duong, MSc</last_name>
      <email>duonga@mcmaster.ca</email>
    </contact>
    <investigator>
      <last_name>Matthew Denkers, MD, FRCSC</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>McMaster University Medical Centre</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N3Z5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Simunovic, MSc</last_name>
      <email>simunon@mcmaster.ca</email>
    </contact>
    <investigator>
      <last_name>Olufemi R Ayeni, MD, PhD, FRCSC</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nolan Horner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aaron Gazendam, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Seper Ekhtiari, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Darren de SA, MD, FRCSC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Devin Peterson, MD, FRCSC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Healthcare Hamilton</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N4A6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andrew Duong, MSc</last_name>
      <email>duonga@mcmaster.ca</email>
    </contact>
    <investigator>
      <last_name>Anthony Adili, MD, FRCSC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Moin Khan, MD, FRCSC</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vickas Khanna, MD, FRCSC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jay Moro, MD, FRCSC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>September 22, 2020</study_first_submitted>
  <study_first_submitted_qc>September 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 28, 2020</study_first_posted>
  <last_update_submitted>February 24, 2021</last_update_submitted>
  <last_update_submitted_qc>February 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>McMaster University</investigator_affiliation>
    <investigator_full_name>Olufemi Ayeni</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics, Non-Narcotic</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No data sharing</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

